Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

60.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional wasteosome accumulation across neurodegenerative diseases points to a shared underlying mechanism potentially related to glymphatic insufficiency.

Acta neuropathologica communications·2026
Same author

Synucleinopathy-like clinical features and biologically defined synuclein seeding in PSP-Parkinsonism: an imperfect match.

NPJ Parkinson's disease·2026
Same author

SAM68 is a multifunctional post-transcriptional regulator of cardiomyocyte differentiation.

Nucleic acids research·2026
Same author

Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.

NPJ Parkinson's disease·2026
Same author

New insight into atypical parkinsonism: a special issue in memory of Gregor Wenning (1964-2024).

Journal of neural transmission (Vienna, Austria : 1996)·2026

Related Experiment Video

Updated: Dec 17, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.0K

Transcriptomic differences in MSA clinical variants.

Alexandra Pérez-Soriano1,2,3, Magdalena Arnal Segura3,4, Teresa Botta-Orfila3,5

  • 1Parkinson's Disease & Movement Disorders Unit, Hospital Clínic/IDIBAPS/CIBERNED/European Reference Network for Rare Neurological Diseases (ERN-RND)/Institut de Neurociències, University of Barcelona, Catalonia, Spain.

Scientific Reports
|June 27, 2020
PubMed
Summary

Multiple system atrophy (MSA) involves distinct gene expression changes in its parkinsonian (MSA-P) and cerebellar (MSA-C) subtypes. These findings suggest differing biological pathways contribute to MSA

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.8K
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

8.0K

Related Experiment Videos

Last Updated: Dec 17, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.0K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.8K
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

8.0K

Area of Science:

  • Neuroscience
  • Genomics
  • Molecular Biology

Background:

  • Multiple system atrophy (MSA) is a rare, fatal neurodegenerative disorder affecting oligodendroglia.
  • It presents with two main clinical variants: MSA with predominant parkinsonism (MSA-P) and MSA with cerebellar dysfunction (MSA-C).
  • The underlying etiopathogenesis of MSA remains largely unknown.

Purpose of the Study:

  • To investigate novel disease mechanisms in MSA by analyzing blood transcriptomic data.
  • To identify differential gene expression and biological process alterations in MSA subtypes (MSA-P and MSA-C).

Main Methods:

  • Blood transcriptomic analysis was performed on small, balanced cohorts.
  • Participants included probable MSA-P (n=10), MSA-C (n=10), healthy controls (n=10), and Parkinson's Disease (PD) patients (n=10).
  • Gene set enrichment analyses were conducted to identify altered biological processes.

Main Results:

  • Immunity and inflammation pathways were upregulated across all MSA and PD groups.
  • Cell differentiation and nervous system development pathways were downregulated in MSA-P and PD.
  • Protein translation and processing pathways showed distinct alterations in MSA-C compared to MSA-P and PD.
  • Distinct gene expression patterns were observed between different synucleinopathies.

Conclusions:

  • Gene expression and biological processes appear to be differentially affected in MSA-P and MSA-C subtypes.
  • These findings suggest distinct molecular mechanisms underlying the clinical variants of MSA.
  • Larger sample sizes are needed to validate these preliminary results.